A new approach to treating bacterial vaginosis
Objective. To carry out a systematic analysis of the data available in the current literature on the efficacy of lactic-acid bacteria, Lactobacillus strains in particular, in treating bacterial vaginosis.Khryanin A.A., Reshetnikov O.V.
Material and methods. The review includes the data of foreign and Russian articles published in the past 10 years and found on this topic.
Results. The paper analyzes the results of the found studies of the efficacy and safety of lactic acid bacteria-containing agents in the treatment of bacterial vaginosis. Their evidence level is estimated.
Conclusion. It is concluded that Provag containing Lactobacillus strains has a clinical effect and safety, which enable its use to be recommended for the treatment of recurrent bacterial vaginosis and aerobic vaginitis. At the same time the drug is also effective in treating other diseases associated with these conditions, papillomavirus infection in particular.
Keywords
bacterial vaginosis
lactic acid bacteria
Lactobacillus strains
provag
Supplementary Materials
References
1. Tsvelev Yu.V., ed. Practical reference of obstetrician-gynecologist. St. Petersburg: Foliant;1995. 384p. (in Russian)
2. Kulakov V.I., red. ed. Obstetric and gynecological care. Practical guidance. Moscow: Meditsinskaya literatura; 2000. (in Russian)
3. Khryanin A.A., Reshetnikov O.V. Bacterial vaginosis: A new paradigm. Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2016; (4): 133-139. (in Russian) http://dx.doi.org/10.18565/aig.2016.4.133-139
4. Levakov S.A., Kedrova A.G., Chelnokova N.N. The use of modern strains of Lactobacillus in the treatment of bacterial vaginosis in premenopausal women. Problemyi reproduktsii. 2013; 19(2): 91-4. (in Russian)
5. Reid G., Charbonneau D., Erb J., Kochanowski B., Beuerman D., Poehner R., Bruce A.W. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 signficantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 2003; 35(2): 131-4.
6. Heczko P.B., Tomusiak A., Adamski P., Jakimiuk A.J., Stefański G., Mikołajczyk-Cichońska A. et al. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial. BMC Womens Health. 2015;15: 115. doi: 10.1186/s12905-015-0246-6.
7. Borisov A.G., Savchenko A.A., Kudryavcev I.V. Features of the immune response during viral infection. Infekcija i immunitet. 2015; 5(2): 148–156. (in Russian)
8. Borisov A.G., Savchenko A.A., Tihonova E.P., Sergeeva I.V., Kasparov E.V., Kudryavtsev I.V., Arutyunyan S.S. The state of the immune system when using probiotic lactobacilli in the complex therapy of papillomavirus infection. Kazanskiy meditsinskiy zhurnal. 2017; 98(1): 20-6. (in Russian)
Received 21.04.2017
Accepted 28.04.2017
About the Authors
Khryanin Alexey Alexeevich, MD, Professor of the Department of Dermatovenereology and Cosmetology, Novosibirsk State Medical University, Ministry of Health of Russia; Vice-President of the Regional Public Organization “Association of Obstetricians/Gynecologists and Dermatovenereologists”.630091, Russia, Novosibirsk, Krasny prospect, 52. E-mail: khryanin@mail.ru
Reshetnikov Oleg Vadimovich, doctor of medical sciences, leading researcher of the Research Institute of Therapy and Preventive Medicine,
Siberian Branch of the Russian Academy of Medical Sciences. 630089, Russia, Novosibirsk, B. Bogatkova str. 175/1. E-mail: reshetnikov_ov@mail.ru
For citations: Khryanin A.A., Reshetnikov O.V. A new approach to treating bacterial vaginosis. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (6): 159-64. (in Russian)
http://dx.doi.org/10.18565/aig.2017.6.159-64
Similar Articles
